The Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma
- PMID: 30159302
- PMCID: PMC6106970
- DOI: 10.1155/2018/4763832
The Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma
Abstract
Hepatocellular carcinoma (HCC) represents a global health problem, with the majority of patients presenting at an advanced or incurable stage. The development of effective systemic therapy options for this disease has been challenging because many HCC patients suffer from underlying liver cirrhosis that precludes the safe delivery of systemic therapy. The current review seeks to provide an overview of the current systemic therapeutic approaches for advanced HCC as well as some of the novel management strategies that are currently being evaluated.
Similar articles
-
Hepatocellular carcinoma: Current situation and challenge.Hepatobiliary Pancreat Dis Int. 2019 Aug;18(4):303-304. doi: 10.1016/j.hbpd.2019.05.013. Epub 2019 Jun 11. Hepatobiliary Pancreat Dis Int. 2019. PMID: 31253577 No abstract available.
-
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma.World J Gastroenterol. 2019 Aug 7;25(29):3870-3896. doi: 10.3748/wjg.v25.i29.3870. World J Gastroenterol. 2019. PMID: 31413525 Free PMC article. Review.
-
Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond.Future Oncol. 2015;11(16):2263-6. doi: 10.2217/fon.15.161. Future Oncol. 2015. PMID: 26260805 No abstract available.
-
Target therapy for hepatocellular carcinoma: is sorafenib for everybody?J Clin Gastroenterol. 2009 May-Jun;43(5):389-90. doi: 10.1097/MCG.0b013e31819eb9a6. J Clin Gastroenterol. 2009. PMID: 19564813 No abstract available.
-
Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review.J Natl Cancer Inst. 2021 Feb 1;113(2):123-136. doi: 10.1093/jnci/djaa119. J Natl Cancer Inst. 2021. PMID: 32898239 Free PMC article.
Cited by
-
[Effect of danusertib on cell cycle, apoptosis and autophagy of hepatocellular carcinoma HepG2 cells in vitro].Nan Fang Yi Ke Da Xue Xue Bao. 2018 Dec 30;38(12):1476-1484. doi: 10.12122/j.issn.1673-4254.2018.12.13. Nan Fang Yi Ke Da Xue Xue Bao. 2018. PMID: 30613017 Free PMC article. Chinese.
-
Association between G-protein coupled receptor 4 expression and microvessel density, clinicopathological characteristics and survival in hepatocellular carcinoma.Oncol Lett. 2020 Apr;19(4):2609-2620. doi: 10.3892/ol.2020.11366. Epub 2020 Feb 5. Oncol Lett. 2020. PMID: 32218811 Free PMC article.
-
Up-Regulation of Phosphatase in Regenerating Liver-3 (PRL-3) Contributes to Malignant Progression of Hepatocellular Carcinoma by Activating Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN)/Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway.Med Sci Monit. 2018 Nov 12;24:8105-8114. doi: 10.12659/MSM.913307. Med Sci Monit. 2018. PMID: 30418964 Free PMC article.
-
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.Cochrane Database Syst Rev. 2020 Jan 24;1(1):CD011313. doi: 10.1002/14651858.CD011313.pub3. Cochrane Database Syst Rev. 2020. Retraction in: Cochrane Database Syst Rev. 2020 Nov 16;11:CD011313. doi: 10.1002/14651858.CD011313.pub4. PMID: 31978267 Free PMC article. Retracted.
-
Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2023 Sep 18;10:1547-1571. doi: 10.2147/JHC.S404424. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37744303 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical